The mechanisms by which genetic variation affects transcription regulation and phenotypes at the nucleotide level are incompletely understood. Here we use natural genetic variation as an in vivo mutagenesis screen to assess the genome-wide effects of sequence variation on lineage-determining and signal-specific transcription factor binding, epigenomics and transcriptional outcomes in primary macrophages from different mouse strains. We find substantial genetic evidence to support the concept that lineage-determining transcription factors define epigenetic and transcriptomic states by selecting enhancer-like regions in the genome in a collaborative fashion and facilitating binding of signal-dependent factors. This hierarchical model of transcription factor function suggests that limited sets of genomic data for lineage-determining transcription factors and informative histone modifications can be used for the prioritization of disease-associated regulatory variants.
The mechanisms by which genetic variation affects transcription regulation and phenotypes at the nucleotide level are incompletely understood. Here we use natural genetic variation as an in vivo mutagenesis screen to assess the genome-wide effects of sequence variation on lineage-determining and signal-specific transcription factor binding, epigenomics and transcriptional outcomes in primary macrophages from different mouse strains. We find substantial genetic evidence to support the concept that lineage-determining transcription factors define epigenetic and transcriptomic states by selecting enhancer-like regions in the genome in a collaborative fashion and facilitating binding of signal-dependent factors. This hierarchical model of transcription factor function suggests that limited sets of genomic data for lineage-determining transcription factors and informative histone modifications can be used for the prioritization of disease-associated regulatory variants.
Inter-individual genetic variation is a major cause of diversity in phenotypes and disease susceptibility. Although sequence variants in gene promoters and protein-coding regions provide obvious prioritization of disease-causing variants, most (88%) genome-wide association study (GWAS) loci are in non-coding DNA, suggesting regulatory functions 1 . Prioritization of functional intergenic variants remains challenging, owing in part to an incomplete understanding of how regulation is achieved at the nucleotide level in different cell types and environmental contexts [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Recent studies have described important roles for lineage-determining transcription factors (LDTFs), also referred to as pioneer factors or master regulators, in selecting celltype-specific enhancers [12] [13] [14] [15] , but the sequence determinants that guide their binding are poorly understood. Previous findings in macrophages and B cells suggest a hierarchical model of regulatory function 6 , in which a relatively small set of LDTFs collaboratively compete with nucleosomes to bind DNA in a cell-type-specific manner (Fig. 1A, a and b). The binding of these factors is proposed to 'prime' DNA by initiating deposition of histone modifications that are associated with cis-active regulatory regions (Fig. 1A, b and c) and enable concurrent or subsequent binding of signal-dependent transcription factors that direct regulated gene expression 6, 13, 15, 16 (Fig. 1A, c-e ). In principle, this model provides a straightforward framework that allows non-coding variants to be classified with respect to their ability to directly perturb LDTF binding and their potential to exert indirect effects on binding of other LDTFs and signal-dependent transcription factors. To test the validity of this model and its ability to explain effects of genetic variation on transcription factor binding and function, we exploited the naturally occurring genetic variation between the inbred C57BL/6J and BALB/cJ mouse strains (,4 million single nucleotide polymorphisms (SNPs) and ,750 k indels 17 ) as an 'in vivo mutagenesis screen'.
Direct effects of genetic variation
First, we quantified genome-wide binding patterns of macrophage LDTFs PU.1 and C/EBPa from both mouse strains using chromatin immunoprecipitation followed by massively parallel sequencing (ChIP-Seq). These experiments identified a combined 82,154 PU.1 and 54,874 C/EBPa peaks, with less than 1% of sites exhibiting highly significant strain-specific binding (PU.1, n 5 496; C/EBPa, n 5 263; fourfold tag count ratio, false discovery rate (FDR) , 1 3 10 214 , .90% located .3 kilobases (kb) from gene promoters) ( Fig. 1B, C and Extended Data Fig. 1a ). Strain-specific binding was defined using biological ChIP-Seq replicates, which yielded ,0.2% empirical false positives (Extended Data Fig. 1b-g) . Differential binding of PU.1 and C/EBPa was significantly correlated with differential expression of the nearest gene as measured by RNA-Seq (Fig. 1D ). There were no apparent differences in genomic context for strain-similar and strain-specific binding at inter-or intragenic sites (.3 kb to promoters) as defined by CpG content, distance from nearest gene or repetitive element, or conservation score (Extended Data Fig. 2a ). Instead, strain-specific binding was highly correlated with polymorphism frequency. We observed fivefold enrichment of polymorphisms at strain-specific versus strainsimilar PU.1-and C/EBPa-bound regions ( Fig. 1E and Extended Data Fig. 2b) , with the greatest variant density at the peak centres (Extended Data Fig. 2c, d) .
To investigate the direct effects of sequence variants on transcription factor binding, we identified the most enriched position weight matrices (PWMs) in genomic regions marked by histone H3 lysine 4 di-methylation (H3K4me2) or bound by PU.1 or C/EBPa (Extended Data Fig. 3a and Supplementary Table 1 ). This analysis consistently identified consensus and degenerate motifs for the LDTFs PU.1, C/EBP and AP-1 as the most highly enriched PWMs. Notably, the frequency of mutations in these motifs increased with strain-specific binding of PU.1 and C/EBPa (Extended Data Fig. 2e , f). Excluding strain-specific loci without cis-variation (,11%), 41% of strain-specific PU.1 binding directly associated with strain-specific mutations in PU.1 motifs in the other strain. For C/EBPa, 44% of strain-specific binding associated with strain-specific C/EBPa motifs ( Fig. 1F ).
Although strain-specific binding of PU.1 and C/EBPa was highly linked to strain-specific motif mutations, strain-specific motif mutations were also associated with strain-similar binding (Extended Data Fig. 3c, d) . This raised the question as to whether specific features of motif mutations could be used to predict strain-specific binding. Comparison of motif mutations in strain-specific and strain-similar peaks revealed three distinct attributes contributing to predictive power. First, mutated motifs within 20 base pairs (bp) of the experimentally defined binding centres were more highly associated with an effect on binding (PU.1, P 5 1.6 3 10 24 ; C/EBPa, P 5 0.036; Extended Data Fig. 4a-d) . Second, the presence of alternative motifs within 100 bp of the PU.1 peak centres significantly buffered the effect of strainspecific PU.1 motifs (Extended Data Fig. 4e , f). Third, after removing peaks with alternative motifs, analysis of the nucleotides mutated enabled delineation of an empirically defined functional motif that revealed a strong relationship between 'core' mutations and altered binding ( Fig. 1G and Extended Data Fig. 4g -i; P 5 3.2 3 10 28 PU.1 and P 5 5.1 3 10 24 C/EBP). Taken together, core motif mutations ,20 bp from the peak centre that lacked alternative motifs were 3.53 and 33 more likely to occur in differential versus similar bound peaks for PU.1 and C/EBPa, respectively (Extended Data Fig. 4j, k) . Notably, up to 90% of these mutations were located in differentially bound peaks (Extended Data Fig. 4l , m). To investigate the possibility that an algorithm incorporating these characteristics could be used to predict the effect of a specific motif mutation on transcription factor binding, we performed ChIP-Seq analysis for PU.1 in macrophages derived from a third inbred strain of mice, NOD/ShiLtJ (NOD). Of the ,1.4 million identifiable PU.1 motifs in the C57BL/6J reference genome, 18,322 contain SNPs that mutate the PU.1 motif in the NOD genome. A total of 1.6% of these mutations were associated with strainspecific binding ( Fig. 1H ). Of the 244 NOD PU.1 motif mutations located in PU.1-bound regions in C57BL/6J or BALB/cJ mice, 68% were associated with strain-specific binding. When considering all three variables (motif distance, alternative motif and motif core; Extended Data Fig. 5 ), 88% of the predicted functional mutations were consistent with impaired PU.1 binding in NOD ( Fig. 1H ).
Variation and collaborative LDTF binding
To investigate the potential effect of mutations in LDTF recognition motifs on collaborative binding, we analysed all strain-specific PU.1 or C/EBPa binding events in regions containing LDTF motif mutations. PU.1 motif mutations resulting in loss of PU.1 binding were frequently associated with a corresponding loss of nearby C/EBPa binding in the absence of C/EBP motif mutations ( Fig. 2a, top) . Conversely, C/EBP motif mutations resulting in a loss of C/EBPa binding were frequently associated with a corresponding loss of nearby PU.1 binding in the absence of PU.1 motif mutations ( Fig. 2a , middle). Similar results were observed at locations containing strain-specific mutations in AP-1 binding motifs, but intact PU.1 and C/EBP motifs (Fig. 2a, bottom) .
We next considered the global relationships of mutations in PU.1, C/EBP and AP-1 motifs with strain-specific binding of PU.1 and C/EBPa, taking into account both consensus and 'weak' motifs for PU.1 and C/EBP. NF-kB motifs were included as controls that were not expected to affect PU.1 or C/EBPa binding in unstimulated macrophages (Extended Data Fig. 3a, b and Supplementary Table 1 ). Although mutations in PU.1 motifs had the strongest effect on strain-specific PU.1 binding, mutations exclusively in C/EBP and/or AP-1 motifs also significantly correlated with differential PU.1 binding relative to similarly bound loci ( Fig. 2b) . Similar relationships were observed for C/EBP (Extended Data Fig. 6a ). The motif distance distributions for co-bound factors were broad (half-width ,100 nucleotides), and only a minor subset of sites exhibited defined distances expected for direct protein-protein text) . B, C, ChIP-Seq-defined binding intensity for PU.1 (B) and C/EBPa (C) in resting macrophages derived from C57BL/6J (C57; x axes) and BALB/cJ (BALB; y axes) mice. Dots represent normalized tag counts in 200-bp peaks. PU.1, C/EBPa and AP-1 motifs that were mutated in one genome (distinguished by symbol; red denotes C57BL/6J, blue denotes BALB/cJ) are highlighted for peaks with strain-specific binding (fourfold, FDR # 1 3 10 214 ). D, RNA-Seq-determined expression for genes nearest to strain-specific PU.1 or C/EBPa peaks. P values are from one-tailed t-test. E, Variant frequency distributions for PU.1 binding ratio bins. Box midlines (D, E) are medians, boundaries are first and third quartiles, and whiskers extend to extremes. F, The percentage of polymorphic, strain-specific PU.1 and C/EBPa peaks with LDTF mutations. G, The observed position of SNPs generating strain-specific PU.1 motifs (n 5 359) underlying differential (blue) or similar (red) PU.1 binding are shown. H, The proportion of NOD PU.1 motif mutations that abolished PU.1 binding for each group is shown (details in Extended Data Fig. 5 ). Alt., alternative.
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interactions (Extended Data Fig. 6b ), suggesting transcription-factornucleosome competition as the driving force behind the collaborative binding behaviour 6, 18 . Together, strain-specific mutations in nearby C/EBP and AP-1 motifs were associated with ,15% of strain-specific PU.1 binding at sites with strain-similar PU.1 motifs. Mutations in nearby PU.1 and AP-1 motifs were associated with ,30% of strainspecific C/EBPa binding at sites with strain-similar C/EBP motifs ( Fig. 1F ). Overall, 48% of strain-specific PU.1 binding and 57% of C/EBPa binding were associated with at least one assignable LDTF motif mutation ( Fig. 1F ). To test genetically whether these correlations are consistent with a collaborative binding model, we considered all LDTF motif mutations and evaluated their effects on PU.1 binding in macrophages derived from NOD mice. For polymorphic strain-specific PU.1 loci containing strain-specific LDTF motifs (n 5 220), PU.1 binding profiles matched the strain with shared alleles for 91% of cases ( Fig. 3a ). At 8% (n 5 17) of the loci, the NOD genome broke the C57BL/6J-BALB/cJ haplotypes, and in all cases, the NOD genotype at the LDTF motif variant matched the strain with similar binding (Supplementary Table 2 ), indicating that these variants are probably the cause of binding differences. An example is shown in Fig. 3b , in which PU.1 binds in C57BL/6J but not in BALB/cJ or NOD mice. Only one SNP in this region is associated with PU.1 binding exclusively in C57BL/6J; here, the T allele forms part of a neighbouring AP-1 motif in C57BL/6J that is mutated by the C allele in BALB/cJ and NOD mice. These findings provide genetic evidence that PU.1 binding to this location is dependent on collaborative interactions with AP-1.
To confirm that the allele-specific binding also occurs in heterozygous cells, we performed ChIP-Seq for PU.1 and C/EBPa in macrophages from CB6F1/J hybrid mice, which are F 1 offspring of a C57/ BL/6J 3 BALB/cJ cross. In the most cases, alleles bound specifically in a parental strain were also bound preferentially in the F 1 generation ( Fig. 3c and Extended Data Fig. 6c ). model. a, Normalized ChIP-Seq signal at 342 loci defined by strain-specific PU.1 and/or C/EBPa binding, and containing LDTF motif mutations (rows) plotted for each factor/modification (columns). Left columns display SNPs as grey dots with mutated motifs highlighted by colour (LDTF mutation labels at left). b, Log 2 odds ratios for observing strain-specific motif mutations at strainspecific (.2-fold tag ratio, left and right bins) and similar (,2-fold tag ratio, middle bin) PU.1 peaks (details in Methods). c, Gene expression for genes nearest promoter-distal (.3 kb), strain-specific H3K4me2 and H3K27ac peaks is shown (described in Fig. 1D ). d, Normalized H3K27ac log 2 tag ratios (1 kb, y axis) versus log 2 (PU.1 3 C/EBPa) tag-strain ratios (200 bp, x axis) for loci with PU.1 or C/EBPa binding. Strain-specific motif mutations are indicated by symbol and colour. The distribution of H3K27ac strain ratios stratified by strain mutations is shown (two-sided t-test). e, Enrichment significance (hypergeometric distribution testing, see Methods) of H3K27ac-modification in eQTLs from different cell types is shown. Mac, macrophage. a, PU.1 binding at strain-specific loci is shown for C57BL/6J, BALB/cJ and NOD/ShiLtJ (NOD) mouse macrophages (columns; red denotes binding, white denotes no binding). All loci contain a strain-specific PU.1, C/EBP or AP-1 motif. The NOD haplotype at these loci is indicated by the sidebar (red denotes BALB/cJ, blue denotes C57BL/6J, yellow denotes a mixture). b, PU.1 binding, SNPs (lines), allele sharing, motif alignment and genome sequence (seq.) are shown for a locus where NOD broke the C57/BALB haplotypes. c, d, Allele-specific ChIP-Seq ratios (y axes) for PU.1 (c) and H3K27ac (d) in CB6F1/J hybrid macrophages versus ChIP-Seq reads in parental strains (BALB/C57 log 2 ratios; x axes) are shown for strain-specific (sp.) peaks (blue denotes C57BL/6J, red denotes BALB/cJ-specific) and similarly (sim.) bound peaks (black) as defined by parental data.
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Given the genetic evidence that LDTFs collaborate to bind DNA, we next tested the extent to which strain-specific LDTF binding explained promoter-distal (.3 kb) strain-specific histone modification events, such as H3K4me2 and H3K27ac deposition, which respectively mark 'primed' and 'active' chromatin 19, 20 (Fig. 1A, b and c). Genomic regions exhibiting strain-specific binding of PU.1 and C/EBPa were associated with strain-specific H3K4me2 and H3K27ac ( Fig. 2a, right) . Strainspecific histone modifications correlated with nearby gene expression ( Fig. 2c) , and H3K27ac modification tracked with the corresponding parental allele in CB6F1/J hybrid mice (Fig. 3d ). Strain-specific binding of PU.1 and C/EBPa was individually correlated with H3Kme2 and H3K27ac deposition, with the combined binding of both factors exhibiting even greater correlation than the individual factors (Extended Data Fig. 7a-f ). Furthermore, LDTF motif mutations segregated with differential LDTF binding and histone modifications ( Fig. 2d and Extended Data Fig. 7g ). Together, these findings support the concept that LDTFs have quantitatively important roles in establishing these histone modifications, probably through initiating transcription in a combinatorial fashion 21 .
Expression quantitative trait loci (eQTLs) are polymorphic loci whose alleles are associated with individual RNA expression levels across a population 22 . Thus, eQTLs define active gene regulatory loci and provide an alternative method for assigning regulatory function to gene expression. To interrogate the relationship between histone modification and eQTLs, we analysed previously reported eQTL data from 85 inbred mouse strains in the hybrid mouse diversity panel in primary macrophages 23 (see Methods). We found that eQTLs overlapped H3K4me2-or H3K27ac-marked regions at frequencies greater than expected by chance, supporting the role of histone modifications as landmarks of regulatory activity (hypergeometric test P values: H3K4me2 5 1 3 10 22,147 , H3K27ac 5 1 3 10 22,290 . Next, given the highly cell-type-specific nature of gene regulation 24 , we proposed that eQTLs from different cell types would be reflected in the histone modification profiles in the same cell type. We examined liver and macrophage eQTLs for a set of ,130 k SNPs from the hybrid mouse diversity panel 25 for overlap with H3K27ac loci defined in macrophages or in liver, pro-B or mouse embryonic stem cells 20 . Macrophage eQTLs were more significantly enriched for overlap with macrophage H3K27ac regions than liver H3K27ac regions. Similarly, liver eQTLs were most significantly enriched with liver H3K27ac relative to macrophage H3K27ac ( Fig. 2e ). Clustering of H3K27ac profiles revealed that liver and embryonic stem-cell H3K27ac profiles are most similar (Extended Data Fig. 7h ), providing an explanation as to why liver eQTLs were highly enriched in mouse embryonic stem-cell H3K27ac regions.
LDTF motif mutations affect NF-kB binding
To evaluate the prediction that primed regulatory loci (containing H3K4me2) often require additional binding of signal-dependent transcription factors to achieve regulatory activity (Fig. 1A , c-e), we treated C57BL/6J and BALB/cJ macrophages with Kdo 2 -lipid A (KLA), a potent and specific agonist of TLR4 (ref. 26) . KLA treatment causes NF-kB to enter the nucleus, bind DNA and regulate several hundred target genes 26, 27 . We performed ChIP-Seq for PU.1, C/EBPa and the p65 (also known as RelA) component of NF-kB in untreated and KLA-treated macrophages, and observed that 61% of sites that gained p65 were pre-bound by PU.1 and/or C/EBPa without KLA. De novo motif analysis indicated that an AP-1 motif was present in 42% of the remaining sites, suggesting that AP-1 is responsible for priming a large proportion of the p65 cistrome (Extended Data Fig. 8a ), in line with previous reports 16 .
To interrogate the dependence of p65 on LDTFs further we focused on sites that gained p65 only in one strain (n 5 932, .90% promoterdistal; Extended Data Fig. 1a, Fig. 4a , fourth column). In most cases, PU.1 and/or C/EBPa were bound before KLA treatment only in the strain exhibiting p65 binding (Fig. 4a ). In addition, strain-specific p65 binding primarily occurred at loci already marked by H3K4me2, and led to an increase of H3K27ac, consistent with the proposed model. To analyse the effects of genetic variation on transcription factor motifs, we performed strain-specific LDTF and NF-kB motif finding in polymorphic strain-specific p65-bound peaks (n 5 750) (Extended Data Fig. 3b ). Notably, p65 binding was influenced by mutations in individual LDTF motifs to a similar extent as mutations in the NF-kB motif itself ( Fig. 4b and Extended Data Fig. 8b ). For strain-specific p65 binding events, 34% could be attributed to assignable mutations in PU.1, C/EBP or AP-1 motifs, whereas 9% could be explained by mutations in the assignable NF-kB motifs themselves (Fig. 4c ). RelA is known to bind to degenerate and non-canonical motifs 28 specific p65-bound regions were segregated into rows according to the bound strain (coloured side bar). Binding/modification is shown with and without 100 ng ml 21 KLA treatment (1/2, third header row). As in Fig. 2a , SNPs are indicated by grey dots and mutated motifs are highlighted by colour (labelled at bottom). b, The log 2 odds ratio for observing strain-specific mutations is shown for bins of p65 binding as described in Fig. 2b . c, The percentage of polymorphic, differentially bound p65 loci containing LDTF or NF-kB motif mutations is shown. d, The ratio of variant counts in strain-specific versus strain-similar peaks (y axis) is shown relative to the peak centres for PU.1-, C/EBPa-and p65-bound peaks in 10-bp bins (x axis), smoothed using cubic spline. e, The relative amount of transcription (GRO-Seq) and mRNA production between strains after KLA treatment at the nearest gene to strainspecific p65 loci is shown. P values are from one-tailed t-test.
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not be captured by de novo motif analysis. To gain motif-independent insight into variant location and strain-specific transcription factor binding, we assessed the variant frequency relative to the centres of strain-specific p65 peaks. Similar to strain-specific PU.1 and C/EBPa peaks, strain-specific p65 peaks are in regions of higher variant density than strain-similar peaks (Extended Data Fig. 8c ). In contrast to LDTFs, in which strain-specifically bound regions have a high variant density at their peak centres, the distribution of variants at strain-specific p65 peaks is significantly different from those of the LDTFs (Kolmogorov-Smirnov P , 0.013), as it contains fewer variants at the peak centres and is broader ( Fig. 4d and Extended Data Fig. 8d-f ). This is consistent with p65 binding being more affected by sequence variation in motifs of neighbouring factors than LDTFs.
Overall, strain-specific p65-bound regulatory sites were significantly correlated with nearby genic transcription and messenger RNA production ( Fig. 4e ). We tested strain-specifically bound and epigenetically marked putative enhancer sequences with strain-specific mutations for differential enhancer function in transient and stable reporter assays (Fig. 5a, b and Extended Data Fig. 9a, b) . We observed the predicted strain-specific enhancer activity for 18 out of 20 of these genomic sequences. Conversely, enhancer elements with sequence variation in non-core nucleotides that were not predicted to alter PU.1 or C/EBP binding and that exhibited strain-similar binding patterns exhibited similar enhancer activity (Extended Data Fig. 10a ).
Lastly, we tested whether the predicted motif-disrupting variants could specifically explain strain-specific enhancer activity by swapping variants at the putative causative alleles in C57BL/6J and BALB/cJ while maintaining the genetic background for the remainder of the enhancer sequences. Representative examples in which reversal of such SNPs in PU.1, C/EBP and p65 motifs reversed strain-specific enhancer activity are illustrated in Fig. 5c and Extended Data Fig. 10b , c. By contrast, reversal of nearby SNPs not predicted to alter LDTF motifs had no effect on strain-specific enhancer activity (Extended Data Fig. 10c ).
Discussion
Together, we have exploited natural genetic variation to test a collaborative model for enhancer selection and function, and conversely explored the ability of this model to explain strain-specific differences in transcription factor binding and epigenetic features associated with functional enhancers in macrophages. These studies provide genetic evidence that LDTFs are dependent on collaborative binding to variably spaced DNA recognition motifs to select enhancers and enable binding of signal-dependent transcription factors. Notably, the variable motif distances observed at loci co-bound by LDTF suggest that collaborative binding does not generally require direct protein-protein interactions between the involved transcription factors. The proposed hierarchical LDTF collaborative model provides a conceptual framework for prioritization of non-coding disease-associated regulatory variants. Although all cells express hundreds of transcription factors, a large fraction of functional enhancers (,70% in macrophages) are characterized by collaborative interactions involving relatively small sets of lineage-determining transcription factors (for example, PU.1, AP-1 and C/EBPs). The requirement for collaborative binding interactions provides an explanation for why transcription factor binding is lost at sites where mutations do not occur in the cognate recognition motif. In the case of NF-kB, for example, mutations in the motifs for LDTFs were approximately three times more likely to result in decreased binding of NF-kB than mutations in the NF-kB-binding site itself.
An essential step in leveraging the collaborative model to pinpoint potential disease-causing variants is the definition of relevant LDTFbinding sites and functionally important variants. At the current level of genome annotation, this cannot be achieved by analysis of DNA sequence alone. For example, there are ,1 3 10 6 -2 3 10 6 identifiable PU.1 motifs in the human 29 and mouse genomes, but less than 10% are actually occupied by PU.1 in macrophages. By experimentally defining strain-similar and strain-specific binding patterns for PU.1, the relevant sites at which mutations can result in altered function are identified. Comparison of PU.1 motif mutations associated with strain-specific versus strain-similar binding allowed the genetic definition of a functional binding matrix and additional distinguishing features that enabled accurate prediction of functional mutations in a third strain. Thus, by collecting a relatively limited set of genomic binding data for LDTFs and informative histone modifications, this analytical approach can be exploited to explain a greater extent of variation in enhancer selection and function than previously possible 7, 10 . To increase the specificity and sensitivity for detecting functional variations further, identification of transcription factor motifs that permit binding but diverge from the consensus PWM, that is, 'weak' motifs, needs to be improved, as such sites are more likely to be affected by mutation 29, 30 . In addition, transcription factors less abundant than LDTFs probably have individually small but collectively significant roles. At a larger scale, non-cis-acting, long-range epigenetic mechanisms may also be important for enhancer selection. A major goal for the future will be to extend these approaches to understanding natural genetic variation associated with human disease.
METHODS SUMMARY
Cell culture. Peritoneal macrophages from male 6-8-week-old mice were thioglycolate-elicited and collected 4 days after injection 6 , plated overnight, and incubated for 1 h in fresh media with or without 100 ng ml 21 KLA 26 . ChIP-Seq and feature identification. ChIP-Seq was performed based on published protocols 6, 16, 31 , on either native chromatin after MNase digestion (H3K4me2) or fixed, sonicated chromatin (PU.1, C/EBPa, H3K27ac and p65). ChIP-Seq libraries were sequenced for 51 cycles on a HiSeq 2000 sequencer (Illumina). Reads from C57BL/6J and BALB/cJ were mapped with low stringency to both the mm9 reference (C57BL/6J) genome and the BALB/cJ contigs 17 , and the 98% of all reads that mapped to both genomes was kept for further analysis. NOD data were mapped to the mm9 reference with low stringency. For CB6F1/J ChIP-Seq experiments, 
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allele-specific reads were identified by alignment without mismatch exclusively to either the mm9 reference (C57BL/6J) genome or BALB/cJ contigs 17 . Data were normalized, ChIP-Seq peaks identified, motifs analysed and variants computed using the HOMER package 6 and custom R scripts.
RNA-Seq and GRO-Seq. RNA-Seq was performed on poly(A) 1 RNA after fragmentation, decapping, 39 and 59 adaptor ligation and reverse transcription. GRO-Seq was performed as described 32 . Data were mapped and analysed as described above. eQTL analysis. Analysis of eQTLs was performed as previously described 23, 25 . External data (GEO accession GSE24164; ref. 20) were mapped to the C57BL/6J genome as described above, and enrichment was tested using the hypergeometric distribution function. Reporter assays. Genomic ,1-kb fragments cloned into a minimal HSV-TK promoter containing luciferase reporter plasmid were assayed in RAW264.7 macrophages after 16 h stimulation with or without 100 ng ml 21 KLA. Data were normalized to co-transfected UB6 promoter-driven control plasmid (transient transfections) or total protein content (stable transfections).
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Animals and cell culture. Thioglycolate-elicited peritoneal macrophages were collected 4 days after injection from male 6-8-week C57BL/6J, BALB/cJ or CB6F1/J hybrid mice, and plated at 20 3 10 6 cells per 15-cm Petri dish in RPMI1640 plus 10% FBS and 13 penicillin-streptomycin. One day after plating, cells were treated with fresh media with or without 100 ng ml 21 KLA for 1 h, and then directly used for downstream analyses. All animal experiments were performed in compliance with the ethical standards set forth by University of California, San Diego's Institutional Annual Care and Use Committee (IUCAC).
ChIP-Seq and feature identification. Media were decanted and cells were fixed at room temperature with either 1% formaldehyde in PBS for 10 min (for PU.1, C/EBPa, G3K27ac ChIPs), or 2 mM disuccinimidylglutarate (DSG, Pierce) and 10% dimethylsulphoxide (DMSO) in PBS for 30 min followed by 1% formaldehyde in PBS for another 15 min (p65). After quenching the reaction by adding glycine to final concentration 0.125 M, cells were washed twice with PBS and snapfrozen in dry-ice and methanol. ChIPs for PU.1 (Santa Cruz, sc-352) and C/EBPa (Santa Cruz, sc-61) were performed as described previously 6 . The H3K27ac (Abcam, ab4729) ChIP was performed in the presence of 1 mM butyric acid. For p65 (Santa Cruz, sc-372), immunoprecipitation conditions were identical to those described before 6 , except that pre-clearing was omitted, and the ChIP was performed with 5 mg antibody (Santa Cruz, sc-372) pre-bound to 50 ml Protein A Dynabeads (Invitrogen) for 30 min in 0.5% BSA in TE buffer, and a final wash with TE buffer plus 50 mM NaCl was performed before elution. ChIP-Seq library preps for the initial p65 ChIPs were performed as described previously 6 ; libraries for the replicates were prepared using magnetic beads similar to described procedures 12 .
ChIPs for H3K4me2 were carried out on MNase-digested chromatin as described previously 31 .
To control for open chromatin and library biases, input chromatin libraries after sonication were sequenced for each strain, crosslinking condition and ChIP lysis protocol. Sequencing libraries were prepared as previously described 6 using barcoded adapters (NextFlex, Bioo Scientific), and sequenced for 51 cycles on a HiSeq 2000 sequencer (Illumina) using CASAVA1.7 or 1.8. C57BL/6J and BALB/cJ demultiplexed fastq files were mapped to both the mm9 reference (C57BL/6J) genome and the BALB/cJ contigs 17 using Bowtie0. 12.7 (ref. 33) with the options '-m 1 --best -n 3 -e 200'. Mapping parameters for C57BL/6J and BALB/cJ data allowed three mismatches in the 28-bp seed sequence, with up to five high quality mismatches in the entire read. NOD ChIP-Seq data were mapped to the mm9 genome using the above options. To identify allelespecific reads from CB6F1/J data, ChIP-seq reads were aligned to the C57BL/6J or BALB/cJ sequence using Bowtie2-2.0.0-b7 (ref. 34 ), allowing 0 mismatches in 32-bp reads with options '-N 0 -L 32 --score-min L,0,0 --gbar 17'. Tags mapping to both genomes were discarded. Resulting allele-specific reads were counted for regions of interest.
For C57BL/6J and BALB/cJ data, reads mapping to only one genome were discarded (,2% of total) to avoid bias caused by mapability differences, and reads mapping to both were assigned to the mm9 genomic location. Genomic binding peaks for transcription factors PU.1, C/EBPa and p65 were identified using the 'findPeaks' command in the HOMER (http://biowhat.ucsd.edu/homer/) software suite 6 , with default settings of '-style factor': 200-bp peaks, with fourfold tag enrichment and 0.001 FDR significance over background (ChIP input), fourfold enrichment over local tags, and normalization to 10 million mapped tags per experiment. H3K4me2 and H3K27ac regions used for initial de novo motif finding (Extended Data Fig. 3a) were identified using the default parameters of 'findPeaks -style histone' with the addition of nucleosome-free region (nfr) centring for H3K4me2 MNase data. For H3K4me2 and H3K27ac peaks identified for comparison to LDTF binding and mutation events (for example, Fig. 2d ), 'findPeaks -style peaks' was used to define more focal, non-gene-associated loci. In particular, H3K27ac regions were identified with 'findPeaks' using options '-style factor -size 1000 -L 2'(twofold enrichment over local tags). H3K27ac peaks were merged between strains using 'mergePeaks -size given', and peaks were resized to 1 kb. Peaks within 3 kb of gene promoters were excluded from further analysis. H3K4me2 peaks were identified using 'findPeaks' with options '-style factor -size 500 -L 2 -C 0' (which allows for unlimited tags considered per genome position as may occur with MNase data). Peaks were then centred on the best nfr within a 1 kb window using 'getPeakTags -nfr'. Peak files between strains were merged with 'mergePeaks -size given' and H3K4me2 tags were counted in 1-kb regions centred on the merged peak file definitions. Peaks were then re-centred based on the best nfr in 1 kb identified by 'getPeakTags -nfr' according to the strain with more H3K4me2 tags. Peaks were extended to 1 kb and restricted to those more than 3 kb from gene promoters. Strain-specific feature and motif identification. To determine strain-specific binding and epigenetic modification events, we counted the number of sequencing tags (normalized to 10 million) at peaks/regions identified in the set of combined peaks/regions from both strains. We normalized the mean peak tag count to be equal in each strain and compared the tag counts in each region and required strain-specific peaks/regions to exhibit $fourfold difference in tag counts and an adjusted cumulative Poisson P value corresponding to FDR , 1 3 10 214 (ref. 35) . These criteria were based on empirical data relating replicate ChIP-seq experiments (Extended Data Fig. 1b, c) . Individual genome sequences for C57BL/6J and BALB/cJ were constructed in regions of interest using the reference (C57BL/6J) sequence and replacing BALB/cJ alleles at SNPs and indels reported in the vcf files from ref. 17 . Strain-specific motifs. De novo motif finding in ChIP-Seq-enriched regions from both mouse strains was used to define PWMs for transcription factors of interest (Extended Data Fig. 3a, b and Supplementary Table 1 ). These PWMs were used to define strain-specific motifs by using the options 'homer2 -find , individual genome sequence .' in HOMER for each genome sequence for the regions of interest. The positions of the identified motifs were compared between strains, taking into account shifts caused by indels relative to peak start coordinates and which DNA strand matched the identified motifs. Motifs with alignments only in one genome were considered strain specific. PolyA-RNA-Seq. For each condition, RNA was isolated from 5 3 10 6 thioglycolateelicited macrophages with Trizol LS, and 15 mg RNA was DNase-treated using TURBO DNase (Ambion) according to the manufacturer's instructions and ethanol-precipitated. PolyA-RNA was selected from 7 mg total RNA using the MicroPoly(A)Purist kit (Ambion), according to the manufacturer's instructions. Isolated RNA was hydrolysed in a total volume of 20 ml with 2 ml RNA fragmentation buffer (Ambion) for 10 min at 70 uC. The reaction was stopped with stop buffer, and buffer was exchanged to Tris, pH 8.5, using P30 size-exclusion columns (Bio-Rad). The fragmented RNA (30 ng) was 59-decapped in a total volume of 21 ml containing 0.5 ml tobacco acid pyrophosphatase (TAP, Epicentre), 2 ml 103 TAP buffer and 1 ml SUPERase-IN, and incubated for 2 h at 37 uC. To dephosphorylate RNA 39 ends, 0.5 ml 103 TAP buffer, 1.5 ml water, 0.5 ml of 0.25 M MgCl 2 (4.17 mM final; 1 mM EDTA for maximum phosphatase activity), and 0.5 ml of 10 mM ATP (0.2 mM final to protect PNK) where added, and the reaction was incubated with 1 ml PNK (Enzymatics) for 50 min at 37 uC. RNA fragments were 59-phosphorylated by adding 10 ml 103 T4 DNA ligase buffer, 63 ml water and 2 ml PNK, and incubated for 60 min at 37 uC. RNA fragments were isolated using Trizol LS, precipitated in the presence of 300 mM sodium acetate and 2 ml glycoblue (Ambion), washed twice with 80% ethanol and dissolved in 4.5 ml water.
To prepare sequencing libraries, 0.5 ml of 9 mM 59-adenylated 39MPX adaptor/ 5Phos/AGATCGGAAGAGCACACGTCTGA/3AmMO/ (IDT, desalted; adenylated with Mth ligase (NEB) according to the manufacturer's instructions, phenol-chloroform/chloroform-extracted, ethanol-precipitated with glycogen and dissolved in water at 9 mM) was heat-denatured together with the RNA for 2 min at 70 uC, and ligated with 100 U truncated T4 RNA ligase 2 K227Q (NEB) in 10 ml 13 T4 RNA ligase buffer without ATP, containing 10 U SUPERase-In and 15% PEG8000 for 2 h at 16 uC. To reduce adaptor dimer formation, 0.5 ml of 10 mM MPX_RT primer 59-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-39 (IDT, desalted) was added and annealed to the ligation product by incubating at 75 uC for 2 min, then 37 uC for 30 min, and 25 uC for 15 min. Finally, 0.5 ml of 5 mM hybrid DNA/RNA sRNA 59h adaptor 59-GTTCAGAGTTCTACArGrUrCrCrGr ArCrGrArUrC-39 (IDT) was ligated to previously capped RNA 59 ends by adding 2 ml T4 RNA ligase buffer, 6 ml 50% PEG8000 (15% final), 1 ml of 10 mM ATP, 9.5 ml water and 0.5 ml (5 U) T4 RNA ligase 1 for 90 min at 20 uC. To 15 ml of ligation reaction, an additional 0.5 ml of 10 mM MPX_RT primer was added, reactions were denatured at 70 uC for 1 min and then placed on ice. RNA was reversetranscribed by adding 3 ml 103 first-strand buffer (4.5 ml water, 1.5 ml of 10 mM dNTP, 3 ml of 0.1 M DTT, 1.5 ml RNaseOUT and 1 ml Superscript III reverse transcriptase (Invitrogen)), and incubating for 30 min at 50 uC. 
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GRO-Seq. GRO-Seq was performed as described previously 32 using 10 7 cells per condition. RNA at RefSeq transcripts was quantified for GRO-Seq and polyA-RNA-Seq by counting the normalized tags (to 10 million tags per experiment) in annotated exons for each RefSeq transcript. Odds ratio calculations and statistical testing. Odds ratios for observing C57BL/6J-specific motif mutations relative to BALB/cJ-specific motif mutations in different classes of bound/modified loci (for example, Fig. 2b ) were calculated using (p 1 /(1 2 p 1 ))/(p 2 /(1 3 p 2 )), in which p 1 is the frequency of C57BL/6J-specific motifs, and p 2 is the frequency of BALB/cJ-specific motifs. For Extended Data Fig. 4j , k, p 1 is the frequency of indicated events occurring in differentially bound loci and p 2 is the frequency in similarly bound loci. Unless otherwise indicated, t-tests were two-sided assuming unequal variance. eQTL analysis. eQTL analysis was performed as previously described 23, 25 . In brief, thioglycolate-elicited peritoneal macrophages were collected from 85 strains of mice. RNA was processed and hybridized to Affymetrix Genome HT_MG-430A. There were 22,416 probe sets analysed after removing individual probes overlapping SNPs and probe sets with 8 or more probes overlapping SNPs. Expression data was RMA normalized.
A total of 3,918,755 SNPs with a minimum minor allele frequency of 10% originating from mouse Perlegen variation data set 36 was imputed across the strains 37 , and filtered to 3,695,041 SNPs based on proximity (,2 Mb) to transcription start sites of transcripts detectable by the microarray. Gene expression for each transcript was associated to SNPs within 2 Mb using the efficient mixed-model association mapping that corrects for population structure 38 . Association P values less than 1 3 10 25 (,1% FDR) were deemed significant 23 . The 3,695,041 SNPs used for association mapping were overlapped with H3K4me2 and H3K27ac regions. Because H3K4me2 and H3K27ac regions ranged from 500 to 1,500 bp whereas haplotype blocks averaged 300 kb, we considered SNPs outside H3K4me2/H3K27ac regions that were in linkage disequilibrium with a SNP in H3K4me2/H3K27ac regions as overlapping. Haplotype blocks were estimated in Haploview 39 using 143 strains with the following options: blockMAFThresh 5 0.1, blockCutLowCI 5 0.8, blockCutHighCI 5 0.98, blockRecHighCI 5 0.9, and blockInformFrac 5 0.95. SNPs in linkage disequilibrium with enhancer SNP were considered markers of H3K4me2 regions. To test for enrichment of significant eQTL in H3K4me2 regions, we used the hypergeometric distribution function as follows: were mapped to the C57BL/6J genome. H3K27ac regions were identified where tag pile-ups exceeded four times the input tags using HOMER 6 , and interrogated for enrichment of significant macrophage eQTLs as described for macrophage H3K4me2 and H3K27ac regions above.
Reporter assays and mutation analysis. One-kilobase enhancers were PCRamplified from C57BL/6J and BALB/cJ genomic DNA using genomic primers not overlapping variants that introduced terminal BamHI, BglII or BclI sites on one end and SalI or XhoI sites on the other end of the PCR products, depending on the restriction site content of the enhancer. These were digested with the respective restriction enzymes and ligated into a modified, BamHI-and SalIdigested pGL4.10 luciferase reporter plasmid (Invitrogen) containing a minimal HSV-TK promoter derived from pTAL-Luc (Clontech) (see Fig. 5a ). Alternatively, 1-kb fragments were amplified using primers that introduced overhangs identical to the sequences flanking the BamHI/SalI tandem site in the pGL4.10 plasmid. Fragments were purified from the PCR reaction by SPRI using magnetic beads and cloned into the BamHI/SalI-cut reporter plasmid described above using Gibson Assembly master mix (NEB) according to the manufacturer's instructions. Mutations were introduced by PCR amplification with complementary primers containing the mutation to be introduced in the centre, followed by DpnI digestion of the template and transformation of bacteria. All constructs were confirmed by sequencing. For each reporter assay, 300 ng plasmid was transfected into RAW264.7 macrophages using SuperFect (Qiagen) together with 300 ng UB6 promoter-driven b-galactosidase reporter for transfection normalization in 24-well plates seeded with 1 3 10 5 cells 24 h before transfection. Twenty-four hours after transfection, media alone (RPMI plus 10% FBS) or media containing 100 ng ml 21 KLA was added for an additional 16 h. Luciferase activity was measured 24 h after transfection using a Veritas microplate luminometer (Turner Biosystems), and normalized to b-galactosidase activity (Applied Biosystem) for transfection efficiency. Each experiment was performed at least three independent times, with each reaction done in triplicates. Data represented as mean 6 s.d. , and statistical significance was determined by a one-sided t-test. Stable transfected cell lines were made by transient co-transfection of the linearized reporter plasmids together with linearized neomycin resistance-expressing pcDNA3 vector as described above, followed by incubation with 275 mg ml 21 geneticin (G418 Sulphate, Invitrogen) for 2-3 weeks. Bulk cells from stably transfected colonies were tested for luciferase activity and normalized to total protein concentration (DC Protein Assay, BioRad). Figure 4 | Effects of cognate motif distance from peak centre, variant position within a motif and the presence of alternative motifs on strain-differential binding of PU.1 and C/EBPa. a-d, PU.1 and C/EBP motif mutations near the experimentally derived peak centre are associated with impaired binding. a, c, The ratios of the frequencies of variant-containing motifs at the given distances from strain-differentially versus strain-similarly bound peak centres (.twofold versus ,twofold tag count ratio) for 570 PU.1 (a) and 278 C/EBP (b) variant-containing motifs are shown, respectively. b, d, The distribution of absolute strain peak tag count ratios of peaks whose centre is at the given distances from mutated PU.1 (b) or C/EBP (d) motifs. Box midlines are medians, and boundaries are first and third quartiles. Whiskers extend to the extreme data points. P values are from two-sided t-test. e, f, Effects of alternative PU.1 and C/EBP motifs and core mutations on binding. The number of non-mutated 'alternative' PU.1 or C/EBP motifs in the strain with a PU.1 or C/EBP motif mutation was counted, and the absolute respective PU.1 or C/EBPa log 2 strain binding ratio is shown. g, Defining the C/EBP motif core by comparing differential versus similar C/EBPa binding. Sequence variants within C/EBP motifs located in loci devoid of alternative C/EBP motifs (n 5 178) were counted according to whether they were in differential (blue) or similar (red) C/EBPa-bound peaks. h, The distribution of PU.1 binding strain log 2 ratios (x axis) is shown for PU.1 mutations located in the PU.1 core and non-core nucleotides (defined in Fig. 1g ). i, The C/EBPa binding strain log 2 ratio is shown for C/EBP core and non-core mutations as defined in g. j, k, Motif mutations predominately occur at differentially bound loci. The odds ratios (x axis; equation shown in box) describing the relative effect of the indicated characteristics of mutated motifs on differential binding relative to similar binding are shown for PU.1 (j) and C/EBPa (k). Whiskers show 95% confidence intervals. nt, nucleotides. l, m, The percentage of respective motif mutations consistent with altered PU.1 (l) and C/EBPa (m) binding is shown for the indicated categories of motif mutations.
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